PRWEB
"With pGOLD technology, afflictions such as cancer, auto-immune disorders, cardiovascular disease, and diabetes can be detected at earlier stages and with better accuracy by creating non-invasive, point-of-care testing. Early detection could significantly change the nature and cost of patient care."
For General Inquiries Email: info@nirmidas.com
For Product Support Email: support@nirmidas.com
Nirmidas Biotech, Inc.
319 N. Bernardo Ave
Mountain View, CA, 94043, USA